Compare Altria Group Inc (MO) vs Nasdaq100 ETF (QQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Altria Group Inc vs Nasdaq100 ETF — how do they compare? Altria Group Inc trades at $65.03 (market cap $114.13B), while Nasdaq100 ETF trades at $720.68. The key difference: Altria Group Inc pays a 6.2% dividend while Nasdaq100 ETF pays none, and Nasdaq100 ETF is trading nearer its 52-week high, Altria Group Inc nearer its low. Which is the better fit depends on your goals.
| MO | QQQ | |
|---|---|---|
Market Cap | $114.13B | — |
Sector | Consumer Staples | — |
52-Week High | $74.92 | $746.16 |
52-Week Low | $54.72 | $558.34 |
Enterprise Value | $136.34B | — |
Dividend Yield | 6.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.
MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.
QQQ trades at $723.03, up 1.17% with strong bullish momentum from moving averages and institutional buying interest. The ETF shows technical strength with a bullish overall signal, though RSI_6 at 88.85 indicates potential near-term overbought conditions. Recent news highlights ongoing institutional accumulation and positive momentum in Nasdaq-100 components.
Outlook remains positive given strong technical momentum and institutional support, though elevated short-term RSI suggests potential consolidation. Key risks include expense ratio comparisons with QQQM and tech sector concentration. Analyst consensus is divided with 50% buy and 50% sell ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →
